Pancreatic cancer, or more specifically pancreatic adenocarcinoma, is the fourth leading cause in cancer mortality. However it is also almost an 100% mortality rate, due to its high metastatic abilities because of the pancreas's connection with many of the body system. Unlike most cancers, treatment for pancreatic adenocarcinoma has not improved over the last decades. By targeting digestive enzymes, and in some cases hormone secreting enzymes involved in the endocrine system, pancreatic cancer is currently almost impossible to control, and impervious to chemotherapy. At the heart of every cancer lies the cancer stem cells, or cells that enable diseases to become metastatic and travel through the bloodstream. Cancer stem cells also allow tumors to relapse and create new tumors. To combat this scientists and medical professionals alike developed the stem-cell therapy. By transferring stem cells such as in bone marrow or fetuses, healthy cells could combat cancer cells and growth in the body. While having success with the brain and blood type cancers, pancreatic cancer has not been fully observed. With limited testing the stem-cell therapy proves to have hopes for increase in treatment, however among other cancers it is still challenged by opposers to human cloning and abortion.
Summary of three questions: (Link does not work)
https://docs.google.com/document/d/1UKdZn_gcNx92rJM5tte6WgSYJ4ASd6y5qWhSyFDc5ro/edit
No comments:
Post a Comment